Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 – Clinical Trial Not Allowed)

Funder: National Institutes of Health Due Date: 9/28/2018 Budget: $4,200,000 Opportunity: RFA-CA-18-002 http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-002.html This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies…

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 – Clinical Trial Not Allowed)

Funder: National Institutes of Health Due Date: 9/28/2018 Budget: $1,000,000 Opportunity: RFA-CA-18-004 http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-004.html This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies…

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 – Clinical Trial Not Allowed)

Funder: National Institutes of Health Due Date: 9/28/2018 Budget: $4,300,000 Opportunity: RFA-CA-18-003 http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-003.html This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies…

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 – Clinical Trial Not Allowed)

Funder: National Institutes of Health Due Date: 9/28/2018 Budget: $900,000 Opportunity: RFA-CA-18-005 http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-005.html This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies…